Population genomic screening

1. Population genomic screening increases clinical appointment attendance in humans (87.3% attendance).

   Human trialn = 189

   Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot · Nature health · 15 Jan 2026

1. Population genomic screening is associated with pathogenic or likely pathogenic variants in humans (2.0% (202/10,263)).

   Human trialn = 10,263

   Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot · Nature health · 15 Jan 2026

Pathogenic or likely pathogenic variants →